0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hospital Acquired Infection Control Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-18O1877
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Hospital Acquired Infection Control Market Insights Forecast to 2028
BUY CHAPTERS

Global Hospital Acquired Infection Control Market Research Report 2024

Code: QYRE-Auto-18O1877
Report
January 2024
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Hospital Acquired Infection Control Market Size

The global Hospital Acquired Infection Control market was valued at US$ 5702.2 million in 2023 and is anticipated to reach US$ 6985.5 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.

Hospital Acquired Infection Control Market

Hospital Acquired Infection Control Market

North American market for Hospital Acquired Infection Control is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Hospital Acquired Infection Control is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Hospital Acquired Infection Control include Pfizer, Roche, Merck, Johnson & Johnson, Abott, Bayer, BD, Kimberly-Clark and Nordion, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Hospital Acquired Infection Control, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital Acquired Infection Control.

Report Scope

The Hospital Acquired Infection Control market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hospital Acquired Infection Control market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hospital Acquired Infection Control manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Hospital Acquired Infection Control Market Report

Report Metric Details
Report Name Hospital Acquired Infection Control Market
Accounted market size in 2023 US$ 5702.2 million
Forecasted market size in 2030 US$ 6985.5 million
CAGR 2.9%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Catheter-associated Urinary Tract Infections (CAUTIs)
  • Surgical Site Infections (SSIs)
  • Central Line-associated Bloodstream Infections (CLABSIs)
  • Respiratory Infections
Segment by Application
  • Hospitals and ICUs
  • Outpatient Care Centers
  • Long-term Care Facilities (LTCFs)
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Roche, Merck, Johnson & Johnson, Abott, Bayer, BD, Kimberly-Clark, Nordion, Cepheid
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Hospital Acquired Infection Control manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Hospital Acquired Infection Control in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Hospital Acquired Infection Control Market growing?

Ans: The Hospital Acquired Infection Control Market witnessing a CAGR of 2.9% during the forecast period 2024-2030.

What is the Hospital Acquired Infection Control Market size in 2030?

Ans: The Hospital Acquired Infection Control Market size in 2030 will be US$ 6985.5 million.

Who are the main players in the Hospital Acquired Infection Control Market report?

Ans: The main players in the Hospital Acquired Infection Control Market are Pfizer, Roche, Merck, Johnson & Johnson, Abott, Bayer, BD, Kimberly-Clark, Nordion, Cepheid

What are the Application segmentation covered in the Hospital Acquired Infection Control Market report?

Ans: The Applications covered in the Hospital Acquired Infection Control Market report are Hospitals and ICUs, Outpatient Care Centers, Long-term Care Facilities (LTCFs)

What are the Type segmentation covered in the Hospital Acquired Infection Control Market report?

Ans: The Types covered in the Hospital Acquired Infection Control Market report are Catheter-associated Urinary Tract Infections (CAUTIs), Surgical Site Infections (SSIs), Central Line-associated Bloodstream Infections (CLABSIs), Respiratory Infections

1 Hospital Acquired Infection Control Market Overview
1.1 Product Overview and Scope of Hospital Acquired Infection Control
1.2 Hospital Acquired Infection Control Segment by Type
1.2.1 Global Hospital Acquired Infection Control Market Value Comparison by Type (2024-2030)
1.2.2 Catheter-associated Urinary Tract Infections (CAUTIs)
1.2.3 Surgical Site Infections (SSIs)
1.2.4 Central Line-associated Bloodstream Infections (CLABSIs)
1.2.5 Respiratory Infections
1.3 Hospital Acquired Infection Control Segment by Application
1.3.1 Global Hospital Acquired Infection Control Market Value by Application: (2024-2030)
1.3.2 Hospitals and ICUs
1.3.3 Outpatient Care Centers
1.3.4 Long-term Care Facilities (LTCFs)
1.4 Global Hospital Acquired Infection Control Market Size Estimates and Forecasts
1.4.1 Global Hospital Acquired Infection Control Revenue 2019-2030
1.4.2 Global Hospital Acquired Infection Control Sales 2019-2030
1.4.3 Global Hospital Acquired Infection Control Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Hospital Acquired Infection Control Market Competition by Manufacturers
2.1 Global Hospital Acquired Infection Control Sales Market Share by Manufacturers (2019-2024)
2.2 Global Hospital Acquired Infection Control Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Hospital Acquired Infection Control Average Price by Manufacturers (2019-2024)
2.4 Global Hospital Acquired Infection Control Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hospital Acquired Infection Control, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hospital Acquired Infection Control, Product Type & Application
2.7 Hospital Acquired Infection Control Market Competitive Situation and Trends
2.7.1 Hospital Acquired Infection Control Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hospital Acquired Infection Control Players Market Share by Revenue
2.7.3 Global Hospital Acquired Infection Control Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hospital Acquired Infection Control Retrospective Market Scenario by Region
3.1 Global Hospital Acquired Infection Control Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Hospital Acquired Infection Control Global Hospital Acquired Infection Control Sales by Region: 2019-2030
3.2.1 Global Hospital Acquired Infection Control Sales by Region: 2019-2024
3.2.2 Global Hospital Acquired Infection Control Sales by Region: 2025-2030
3.3 Global Hospital Acquired Infection Control Global Hospital Acquired Infection Control Revenue by Region: 2019-2030
3.3.1 Global Hospital Acquired Infection Control Revenue by Region: 2019-2024
3.3.2 Global Hospital Acquired Infection Control Revenue by Region: 2025-2030
3.4 North America Hospital Acquired Infection Control Market Facts & Figures by Country
3.4.1 North America Hospital Acquired Infection Control Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Hospital Acquired Infection Control Sales by Country (2019-2030)
3.4.3 North America Hospital Acquired Infection Control Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hospital Acquired Infection Control Market Facts & Figures by Country
3.5.1 Europe Hospital Acquired Infection Control Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Hospital Acquired Infection Control Sales by Country (2019-2030)
3.5.3 Europe Hospital Acquired Infection Control Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hospital Acquired Infection Control Market Facts & Figures by Country
3.6.1 Asia Pacific Hospital Acquired Infection Control Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Hospital Acquired Infection Control Sales by Country (2019-2030)
3.6.3 Asia Pacific Hospital Acquired Infection Control Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Hospital Acquired Infection Control Market Facts & Figures by Country
3.7.1 Latin America Hospital Acquired Infection Control Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Hospital Acquired Infection Control Sales by Country (2019-2030)
3.7.3 Latin America Hospital Acquired Infection Control Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hospital Acquired Infection Control Market Facts & Figures by Country
3.8.1 Middle East and Africa Hospital Acquired Infection Control Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Hospital Acquired Infection Control Sales by Country (2019-2030)
3.8.3 Middle East and Africa Hospital Acquired Infection Control Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hospital Acquired Infection Control Sales by Type (2019-2030)
4.1.1 Global Hospital Acquired Infection Control Sales by Type (2019-2024)
4.1.2 Global Hospital Acquired Infection Control Sales by Type (2025-2030)
4.1.3 Global Hospital Acquired Infection Control Sales Market Share by Type (2019-2030)
4.2 Global Hospital Acquired Infection Control Revenue by Type (2019-2030)
4.2.1 Global Hospital Acquired Infection Control Revenue by Type (2019-2024)
4.2.2 Global Hospital Acquired Infection Control Revenue by Type (2025-2030)
4.2.3 Global Hospital Acquired Infection Control Revenue Market Share by Type (2019-2030)
4.3 Global Hospital Acquired Infection Control Price by Type (2019-2030)
5 Segment by Application
5.1 Global Hospital Acquired Infection Control Sales by Application (2019-2030)
5.1.1 Global Hospital Acquired Infection Control Sales by Application (2019-2024)
5.1.2 Global Hospital Acquired Infection Control Sales by Application (2025-2030)
5.1.3 Global Hospital Acquired Infection Control Sales Market Share by Application (2019-2030)
5.2 Global Hospital Acquired Infection Control Revenue by Application (2019-2030)
5.2.1 Global Hospital Acquired Infection Control Revenue by Application (2019-2024)
5.2.2 Global Hospital Acquired Infection Control Revenue by Application (2025-2030)
5.2.3 Global Hospital Acquired Infection Control Revenue Market Share by Application (2019-2030)
5.3 Global Hospital Acquired Infection Control Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Hospital Acquired Infection Control Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Hospital Acquired Infection Control Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Roche
6.2.1 Roche Corporation Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche Hospital Acquired Infection Control Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Roche Hospital Acquired Infection Control Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Hospital Acquired Infection Control Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Hospital Acquired Infection Control Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Hospital Acquired Infection Control Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Johnson & Johnson Hospital Acquired Infection Control Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Abott
6.5.1 Abott Corporation Information
6.5.2 Abott Description and Business Overview
6.5.3 Abott Hospital Acquired Infection Control Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Abott Hospital Acquired Infection Control Product Portfolio
6.5.5 Abott Recent Developments/Updates
6.6 Bayer
6.6.1 Bayer Corporation Information
6.6.2 Bayer Description and Business Overview
6.6.3 Bayer Hospital Acquired Infection Control Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bayer Hospital Acquired Infection Control Product Portfolio
6.6.5 Bayer Recent Developments/Updates
6.7 BD
6.6.1 BD Corporation Information
6.6.2 BD Description and Business Overview
6.6.3 BD Hospital Acquired Infection Control Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BD Hospital Acquired Infection Control Product Portfolio
6.7.5 BD Recent Developments/Updates
6.8 Kimberly-Clark
6.8.1 Kimberly-Clark Corporation Information
6.8.2 Kimberly-Clark Description and Business Overview
6.8.3 Kimberly-Clark Hospital Acquired Infection Control Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Kimberly-Clark Hospital Acquired Infection Control Product Portfolio
6.8.5 Kimberly-Clark Recent Developments/Updates
6.9 Nordion
6.9.1 Nordion Corporation Information
6.9.2 Nordion Description and Business Overview
6.9.3 Nordion Hospital Acquired Infection Control Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Nordion Hospital Acquired Infection Control Product Portfolio
6.9.5 Nordion Recent Developments/Updates
6.10 Cepheid
6.10.1 Cepheid Corporation Information
6.10.2 Cepheid Description and Business Overview
6.10.3 Cepheid Hospital Acquired Infection Control Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Cepheid Hospital Acquired Infection Control Product Portfolio
6.10.5 Cepheid Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hospital Acquired Infection Control Industry Chain Analysis
7.2 Hospital Acquired Infection Control Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hospital Acquired Infection Control Production Mode & Process
7.4 Hospital Acquired Infection Control Sales and Marketing
7.4.1 Hospital Acquired Infection Control Sales Channels
7.4.2 Hospital Acquired Infection Control Distributors
7.5 Hospital Acquired Infection Control Customers
8 Hospital Acquired Infection Control Market Dynamics
8.1 Hospital Acquired Infection Control Industry Trends
8.2 Hospital Acquired Infection Control Market Drivers
8.3 Hospital Acquired Infection Control Market Challenges
8.4 Hospital Acquired Infection Control Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Hospital Acquired Infection Control Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Hospital Acquired Infection Control Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Hospital Acquired Infection Control Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Hospital Acquired Infection Control Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Hospital Acquired Infection Control Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Hospital Acquired Infection Control Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Hospital Acquired Infection Control Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Hospital Acquired Infection Control Average Price (USD/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Hospital Acquired Infection Control, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Hospital Acquired Infection Control, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Hospital Acquired Infection Control, Product Type & Application
    Table 12. Global Key Manufacturers of Hospital Acquired Infection Control, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Hospital Acquired Infection Control by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital Acquired Infection Control as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Hospital Acquired Infection Control Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Hospital Acquired Infection Control Sales by Region (2019-2024) & (K Units)
    Table 18. Global Hospital Acquired Infection Control Sales Market Share by Region (2019-2024)
    Table 19. Global Hospital Acquired Infection Control Sales by Region (2025-2030) & (K Units)
    Table 20. Global Hospital Acquired Infection Control Sales Market Share by Region (2025-2030)
    Table 21. Global Hospital Acquired Infection Control Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Hospital Acquired Infection Control Revenue Market Share by Region (2019-2024)
    Table 23. Global Hospital Acquired Infection Control Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Hospital Acquired Infection Control Revenue Market Share by Region (2025-2030)
    Table 25. North America Hospital Acquired Infection Control Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Hospital Acquired Infection Control Sales by Country (2019-2024) & (K Units)
    Table 27. North America Hospital Acquired Infection Control Sales by Country (2025-2030) & (K Units)
    Table 28. North America Hospital Acquired Infection Control Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Hospital Acquired Infection Control Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Hospital Acquired Infection Control Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Hospital Acquired Infection Control Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Hospital Acquired Infection Control Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Hospital Acquired Infection Control Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Hospital Acquired Infection Control Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Hospital Acquired Infection Control Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Hospital Acquired Infection Control Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Hospital Acquired Infection Control Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Hospital Acquired Infection Control Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Hospital Acquired Infection Control Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Hospital Acquired Infection Control Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Hospital Acquired Infection Control Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Hospital Acquired Infection Control Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Hospital Acquired Infection Control Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Hospital Acquired Infection Control Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Hospital Acquired Infection Control Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Hospital Acquired Infection Control Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Hospital Acquired Infection Control Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Hospital Acquired Infection Control Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Hospital Acquired Infection Control Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Hospital Acquired Infection Control Sales (K Units) by Type (2019-2024)
    Table 51. Global Hospital Acquired Infection Control Sales (K Units) by Type (2025-2030)
    Table 52. Global Hospital Acquired Infection Control Sales Market Share by Type (2019-2024)
    Table 53. Global Hospital Acquired Infection Control Sales Market Share by Type (2025-2030)
    Table 54. Global Hospital Acquired Infection Control Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Hospital Acquired Infection Control Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Hospital Acquired Infection Control Revenue Market Share by Type (2019-2024)
    Table 57. Global Hospital Acquired Infection Control Revenue Market Share by Type (2025-2030)
    Table 58. Global Hospital Acquired Infection Control Price (USD/Unit) by Type (2019-2024)
    Table 59. Global Hospital Acquired Infection Control Price (USD/Unit) by Type (2025-2030)
    Table 60. Global Hospital Acquired Infection Control Sales (K Units) by Application (2019-2024)
    Table 61. Global Hospital Acquired Infection Control Sales (K Units) by Application (2025-2030)
    Table 62. Global Hospital Acquired Infection Control Sales Market Share by Application (2019-2024)
    Table 63. Global Hospital Acquired Infection Control Sales Market Share by Application (2025-2030)
    Table 64. Global Hospital Acquired Infection Control Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Hospital Acquired Infection Control Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Hospital Acquired Infection Control Revenue Market Share by Application (2019-2024)
    Table 67. Global Hospital Acquired Infection Control Revenue Market Share by Application (2025-2030)
    Table 68. Global Hospital Acquired Infection Control Price (USD/Unit) by Application (2019-2024)
    Table 69. Global Hospital Acquired Infection Control Price (USD/Unit) by Application (2025-2030)
    Table 70. Pfizer Corporation Information
    Table 71. Pfizer Description and Business Overview
    Table 72. Pfizer Hospital Acquired Infection Control Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 73. Pfizer Hospital Acquired Infection Control Product
    Table 74. Pfizer Recent Developments/Updates
    Table 75. Roche Corporation Information
    Table 76. Roche Description and Business Overview
    Table 77. Roche Hospital Acquired Infection Control Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 78. Roche Hospital Acquired Infection Control Product
    Table 79. Roche Recent Developments/Updates
    Table 80. Merck Corporation Information
    Table 81. Merck Description and Business Overview
    Table 82. Merck Hospital Acquired Infection Control Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 83. Merck Hospital Acquired Infection Control Product
    Table 84. Merck Recent Developments/Updates
    Table 85. Johnson & Johnson Corporation Information
    Table 86. Johnson & Johnson Description and Business Overview
    Table 87. Johnson & Johnson Hospital Acquired Infection Control Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 88. Johnson & Johnson Hospital Acquired Infection Control Product
    Table 89. Johnson & Johnson Recent Developments/Updates
    Table 90. Abott Corporation Information
    Table 91. Abott Description and Business Overview
    Table 92. Abott Hospital Acquired Infection Control Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 93. Abott Hospital Acquired Infection Control Product
    Table 94. Abott Recent Developments/Updates
    Table 95. Bayer Corporation Information
    Table 96. Bayer Description and Business Overview
    Table 97. Bayer Hospital Acquired Infection Control Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 98. Bayer Hospital Acquired Infection Control Product
    Table 99. Bayer Recent Developments/Updates
    Table 100. BD Corporation Information
    Table 101. BD Description and Business Overview
    Table 102. BD Hospital Acquired Infection Control Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 103. BD Hospital Acquired Infection Control Product
    Table 104. BD Recent Developments/Updates
    Table 105. Kimberly-Clark Corporation Information
    Table 106. Kimberly-Clark Description and Business Overview
    Table 107. Kimberly-Clark Hospital Acquired Infection Control Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 108. Kimberly-Clark Hospital Acquired Infection Control Product
    Table 109. Kimberly-Clark Recent Developments/Updates
    Table 110. Nordion Corporation Information
    Table 111. Nordion Description and Business Overview
    Table 112. Nordion Hospital Acquired Infection Control Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 113. Nordion Hospital Acquired Infection Control Product
    Table 114. Nordion Recent Developments/Updates
    Table 115. Cepheid Corporation Information
    Table 116. Cepheid Description and Business Overview
    Table 117. Cepheid Hospital Acquired Infection Control Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 118. Cepheid Hospital Acquired Infection Control Product
    Table 119. Cepheid Recent Developments/Updates
    Table 120. Key Raw Materials Lists
    Table 121. Raw Materials Key Suppliers Lists
    Table 122. Hospital Acquired Infection Control Distributors List
    Table 123. Hospital Acquired Infection Control Customers List
    Table 124. Hospital Acquired Infection Control Market Trends
    Table 125. Hospital Acquired Infection Control Market Drivers
    Table 126. Hospital Acquired Infection Control Market Challenges
    Table 127. Hospital Acquired Infection Control Market Restraints
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Hospital Acquired Infection Control
    Figure 2. Global Hospital Acquired Infection Control Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Hospital Acquired Infection Control Market Share by Type in 2023 & 2030
    Figure 4. Catheter-associated Urinary Tract Infections (CAUTIs) Product Picture
    Figure 5. Surgical Site Infections (SSIs) Product Picture
    Figure 6. Central Line-associated Bloodstream Infections (CLABSIs) Product Picture
    Figure 7. Respiratory Infections Product Picture
    Figure 8. Global Hospital Acquired Infection Control Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Hospital Acquired Infection Control Market Share by Application in 2023 & 2030
    Figure 10. Hospitals and ICUs
    Figure 11. Outpatient Care Centers
    Figure 12. Long-term Care Facilities (LTCFs)
    Figure 13. Global Hospital Acquired Infection Control Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Hospital Acquired Infection Control Market Size (2019-2030) & (US$ Million)
    Figure 15. Global Hospital Acquired Infection Control Sales (2019-2030) & (K Units)
    Figure 16. Global Hospital Acquired Infection Control Average Price (USD/Unit) & (2019-2030)
    Figure 17. Hospital Acquired Infection Control Report Years Considered
    Figure 18. Hospital Acquired Infection Control Sales Share by Manufacturers in 2023
    Figure 19. Global Hospital Acquired Infection Control Revenue Share by Manufacturers in 2023
    Figure 20. The Global 5 and 10 Largest Hospital Acquired Infection Control Players: Market Share by Revenue in 2023
    Figure 21. Hospital Acquired Infection Control Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 22. Global Hospital Acquired Infection Control Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 23. North America Hospital Acquired Infection Control Sales Market Share by Country (2019-2030)
    Figure 24. North America Hospital Acquired Infection Control Revenue Market Share by Country (2019-2030)
    Figure 25. U.S. Hospital Acquired Infection Control Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Canada Hospital Acquired Infection Control Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. Europe Hospital Acquired Infection Control Sales Market Share by Country (2019-2030)
    Figure 28. Europe Hospital Acquired Infection Control Revenue Market Share by Country (2019-2030)
    Figure 29. Germany Hospital Acquired Infection Control Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. France Hospital Acquired Infection Control Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. U.K. Hospital Acquired Infection Control Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Italy Hospital Acquired Infection Control Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Russia Hospital Acquired Infection Control Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Hospital Acquired Infection Control Sales Market Share by Region (2019-2030)
    Figure 35. Asia Pacific Hospital Acquired Infection Control Revenue Market Share by Region (2019-2030)
    Figure 36. China Hospital Acquired Infection Control Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Japan Hospital Acquired Infection Control Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. South Korea Hospital Acquired Infection Control Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. India Hospital Acquired Infection Control Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Australia Hospital Acquired Infection Control Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Taiwan Hospital Acquired Infection Control Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Indonesia Hospital Acquired Infection Control Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Thailand Hospital Acquired Infection Control Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Malaysia Hospital Acquired Infection Control Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Philippines Hospital Acquired Infection Control Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Latin America Hospital Acquired Infection Control Sales Market Share by Country (2019-2030)
    Figure 47. Latin America Hospital Acquired Infection Control Revenue Market Share by Country (2019-2030)
    Figure 48. Mexico Hospital Acquired Infection Control Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Brazil Hospital Acquired Infection Control Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Argentina Hospital Acquired Infection Control Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Middle East & Africa Hospital Acquired Infection Control Sales Market Share by Country (2019-2030)
    Figure 52. Middle East & Africa Hospital Acquired Infection Control Revenue Market Share by Country (2019-2030)
    Figure 53. Turkey Hospital Acquired Infection Control Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Hospital Acquired Infection Control Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. UAE Hospital Acquired Infection Control Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 56. Global Sales Market Share of Hospital Acquired Infection Control by Type (2019-2030)
    Figure 57. Global Revenue Market Share of Hospital Acquired Infection Control by Type (2019-2030)
    Figure 58. Global Hospital Acquired Infection Control Price (USD/Unit) by Type (2019-2030)
    Figure 59. Global Sales Market Share of Hospital Acquired Infection Control by Application (2019-2030)
    Figure 60. Global Revenue Market Share of Hospital Acquired Infection Control by Application (2019-2030)
    Figure 61. Global Hospital Acquired Infection Control Price (USD/Unit) by Application (2019-2030)
    Figure 62. Hospital Acquired Infection Control Value Chain
    Figure 63. Hospital Acquired Infection Control Production Process
    Figure 64. Channels of Distribution (Direct Vs Distribution)
    Figure 65. Distributors Profiles
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Dengue Testing Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-26K6048
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Ebola Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-20L6129
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Cytomegalovirus Infection Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-4F6384
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global IVD Infectious Diseases Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-16N6009
Mon Apr 15 00:00:00 UTC 2024

Add to Cart